Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study
Abstract Background Patients diagnosed with cancer of unknown primary (CUP) have limited treatment options, resulting in a dismal prognosis. The efficacy of immune checkpoint inhibitors (ICIs) in these patients is still unclear. Methods We collected the clinical data of these patients retrospectivel...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-08-01
|
| Seri Bilgileri: | BMC Cancer |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12885-025-14778-6 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|